Clinical & Diagnostic
Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, and Dexa Medica, a leading Indonesian pharmaceutical company, today ...
October 07, 2021 | News
Researchers initially conducted behavior tests to assess learning, memory, anxiety and depression in mouse models expressing a human amyloid precursor prot...
October 06, 2021 | News
“The collaboration with FUJIFILM Wako to provide iSWAB Microbiome-EL sample collection tubes for molecular testing of COVID-19 by PCR and LAMP based ...
October 05, 2021 | News
Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Awar...
October 05, 2021 | News
The annual business revenue of the biomedical industry in Binhai is expected to reach 100 billion yuan ($15.44 billion) by 2025 with the ...
October 01, 2021 | News
Zantrene® at low concentrations kills high FTO producing melanoma cancer cells Sensitivity to Zantrene® correlates with FTO levels, where high F...
September 30, 2021 | News
The Citeline Awards were created to recognize accomplishments across the biopharmaceutical industry, providing an opportunity for the industry to honor its...
September 24, 2021 | News
The precision health movement, which is valued at tens of billions of dollars, is already afoot, and hospitals and healthcare companies are investing in to...
September 23, 2021 | News
ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...
September 23, 2021 | News
Around 9,000 New Zealanders die of cancer every year.[2] New campaign launched today encourages people to get unusual and persistent symptoms chec...
September 20, 2021 | News
The multi-ministerial project is overseen by the Ministry of Health and Welfare, Ministry of Trade and Industry, Ministry of Science and ICT, and Korea Dis...
September 20, 2021 | News
The Exablate 4000 (Exablate Neuro) platform uses MR-guided focused ultrasound to precisely ablate a small target deep within the brain without incisio...
September 20, 2021 | News
Collaboration consolidates Everest's leadership in the renal space Everest Medicines will pay Sinovent and SinoMab USD $12 million in upfront and up to $5...
September 17, 2021 | News
Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more tha...
September 15, 2021 | News
Most Read
Bio Jobs
News